title: Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus.
abstract: A 31-year-old woman who had developed systemic lupus erythematosus at 17 years of age was admitted to the hospital for suspected cellulitis in the lower extremities. A blood culture performed upon admission to the hospital detected Helicobacter cinaedi (H. cinaedi), which was also isolated in blood and fecal cultures obtained on the 42nd hospital day. Bacterial translocation of H. cinaedi present in the intestines may have led to the development of recurrent bacteremia and cellulitis. In cases such as this, appropriate antibiotics therapy might be needed for more than one month. Moreover, H. cinaedi, a cause of emerging infections, requires a long period of time to grow; therefore it is important to extend the culture duration when the presence of this bacterium is suspected.
authors.affiliation: Department of Microbiology and Immunology, Teikyo University School of Medicine, Japan. hiro-k@med.teikyo-u.ac.jp
authors.forename: Hirotoshi
authors.initials: H
authors.lastname: Kikuchi
authors.forename: Kurumi
authors.initials: K
authors.lastname: Asako
authors.forename: Shigeru
authors.initials: S
authors.lastname: Tansho
authors.forename: Takane
authors.initials: T
authors.lastname: Ueda
authors.forename: Osamu
authors.initials: O
authors.lastname: Koshio
authors.forename: Tuneyuki
authors.initials: T
authors.lastname: Ubagai
authors.forename: Miwa
authors.initials: M
authors.lastname: Asahara
authors.forename: Sayoko
authors.initials: S
authors.lastname: Kawakami
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Ono
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001398:Aztreonam / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D002481:Cellulitis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D021821:Communicable Diseases, Emerging / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D016998:Helicobacter / Q000302:isolation & purification; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D012008:Recurrence
chemical_list: D000900:Anti-Bacterial Agents; D001398:Aztreonam